Effective secondary care teams
publication date: May 23, 2006
During the last few years, there has been a subtle shift of emphasis in the world of sales force representatives. Nowadays, most new products are being launched into the secondary care and specialist markets such as oncology and cardiology. For example, in 2001, of the top 200 pharmaceutical products by sales, 31 per cent were in the secondary care arena. By 2008 the ratio of products with predicted blockbuster status could be 50:50.
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
Why should I register online with European Pharmaceutical Review?
